IL259561B - Methods for predicting the progression of Barrett's esophagus - Google Patents

Methods for predicting the progression of Barrett's esophagus

Info

Publication number
IL259561B
IL259561B IL259561A IL25956118A IL259561B IL 259561 B IL259561 B IL 259561B IL 259561 A IL259561 A IL 259561A IL 25956118 A IL25956118 A IL 25956118A IL 259561 B IL259561 B IL 259561B
Authority
IL
Israel
Prior art keywords
barrett
esophagus
methods
predicting progression
predicting
Prior art date
Application number
IL259561A
Other languages
English (en)
Hebrew (he)
Other versions
IL259561A (en
Inventor
J Thorne Rebecca
Original Assignee
Cernostics Inc
J Thorne Rebecca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cernostics Inc, J Thorne Rebecca filed Critical Cernostics Inc
Publication of IL259561A publication Critical patent/IL259561A/en
Publication of IL259561B publication Critical patent/IL259561B/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
IL259561A 2015-11-25 2018-05-23 Methods for predicting the progression of Barrett's esophagus IL259561B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562260010P 2015-11-25 2015-11-25
PCT/US2016/063482 WO2017091658A1 (en) 2015-11-25 2016-11-23 Methods of predicting progression of barrett's esophagus

Publications (2)

Publication Number Publication Date
IL259561A IL259561A (en) 2018-07-31
IL259561B true IL259561B (en) 2020-06-30

Family

ID=58763606

Family Applications (2)

Application Number Title Priority Date Filing Date
IL259561A IL259561B (en) 2015-11-25 2018-05-23 Methods for predicting the progression of Barrett's esophagus
IL275126A IL275126B (en) 2015-11-25 2020-06-04 Methods for predicting the progression of Barrett's esophagus

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL275126A IL275126B (en) 2015-11-25 2020-06-04 Methods for predicting the progression of Barrett's esophagus

Country Status (7)

Country Link
US (2) US10962544B2 (de)
EP (3) EP3380840B1 (de)
AU (2) AU2016359685B2 (de)
CA (1) CA3006356A1 (de)
ES (2) ES2931924T3 (de)
IL (2) IL259561B (de)
WO (1) WO2017091658A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012229102B2 (en) 2011-03-17 2016-02-04 Cernostics, Inc. Systems and compositions for diagnosing Barrett's esophagus and methods of using the same
US10962544B2 (en) 2015-11-25 2021-03-30 Cernostics, Inc. Methods of predicting progression of Barrett's esophagus
WO2024039692A1 (en) * 2022-08-16 2024-02-22 The Regents Of The University Of California Chromosome 9p24 loss and gain predicts resistance and benefit of immune checkpoint inhibitors

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1791192A (en) 1991-04-05 1992-11-02 Pattern Recognition Direct data base analysis, forecasting and diagnosis method
US6025128A (en) 1994-09-29 2000-02-15 The University Of Tulsa Prediction of prostate cancer progression by analysis of selected predictive parameters
WO1997014028A2 (en) 1995-10-11 1997-04-17 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US5989835A (en) 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US6103479A (en) 1996-05-30 2000-08-15 Cellomics, Inc. Miniaturized cell array methods and apparatus for cell-based screening
US6059724A (en) 1997-02-14 2000-05-09 Biosignal, Inc. System for predicting future health
US6727071B1 (en) 1997-02-27 2004-04-27 Cellomics, Inc. System for cell-based screening
US6416959B1 (en) 1997-02-27 2002-07-09 Kenneth Giuliano System for cell-based screening
US6759206B1 (en) 1997-02-27 2004-07-06 Cellomics, Inc. System for cell-based screening
US7117098B1 (en) 1997-02-27 2006-10-03 Cellomics, Inc. Machine-readable storage medium for analyzing distribution of macromolecules between the cell membrane and the cell cytoplasm
US7853411B2 (en) 1997-02-27 2010-12-14 Cellomics, Inc. System for cell-based screening
ATE268008T1 (de) 1997-02-27 2004-06-15 Cellomics Inc Ein system zur zellbasierten reihenuntersuchung
US6767704B2 (en) 2000-03-27 2004-07-27 Thomas Jefferson University Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression
US6259807B1 (en) 1997-05-14 2001-07-10 Applied Imaging Corp. Identification of objects of interest using multiple illumination schemes and finding overlap of features in corresponding multiple images
US6324479B1 (en) 1998-05-08 2001-11-27 Rosetta Impharmatics, Inc. Methods of determining protein activity levels using gene expression profiles
US6218122B1 (en) 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
WO2000026408A2 (en) 1998-10-30 2000-05-11 Cellomics, Inc. A system for cell-based screening
US20030228565A1 (en) 2000-04-26 2003-12-11 Cytokinetics, Inc. Method and apparatus for predictive cellular bioinformatics
WO2000070528A2 (en) 1999-05-14 2000-11-23 Cytokinetics, Inc. Method and apparatus for predictive cellular bioinformatics
US6986993B1 (en) 1999-08-05 2006-01-17 Cellomics, Inc. System for cell-based screening
CA2390305A1 (en) 1999-11-03 2001-05-10 Oncotech, Inc. Methods for cancer prognosis and diagnosis
AU2001229637A1 (en) 2000-01-21 2001-07-31 Thomas Jefferson University Nipple aspirate fluid specific microarrays
US6763307B2 (en) 2000-03-06 2004-07-13 Bioseek, Inc. Patient classification
CA2405431A1 (en) 2000-03-31 2001-10-11 Gene Logic, Inc. Gene expression profiles in esophageal tissue
CA2414626A1 (en) 2000-07-04 2002-01-10 Bioimage A/S A method for extracting quantitative information relating to interactions between cellular components
US20030096243A1 (en) 2000-09-28 2003-05-22 Busa William Brian Methods and reagents for live-cell gene expression quantification
WO2002077903A2 (en) 2001-03-26 2002-10-03 Cellomics, Inc. Methods for determining the organization of a cellular component of interest
US7219016B2 (en) 2001-04-20 2007-05-15 Yale University Systems and methods for automated analysis of cells and tissues
US20040043436A1 (en) 2001-09-21 2004-03-04 Antonia Vlahou Biomarkers of transitional cell carcinoma of the bladder
US7274809B2 (en) 2002-08-29 2007-09-25 Perceptronix Medical, Inc. And British Columbia Cancer Agency Computerized methods and systems related to the detection of malignancy-associated changes (MAC) to detect cancer
US7801361B2 (en) 2002-10-15 2010-09-21 Definiens Ag Analyzing pixel data using image, thematic and object layers of a computer-implemented network structure
WO2004044555A2 (en) 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
EP1597353B1 (de) 2003-02-27 2010-11-24 Veridex, LLC ZIRKULIERENDE TUMORZELLEN (CTC's): FRÜHE BEURTEILUNG VON TIME-TO-PROGRESSION, ÜBERLEBEN UND ANSPRECHEN AUF THERAPIE BEI PATIENTEN MIT METASTASIERTEM KREBS
US20070135997A1 (en) 2003-04-23 2007-06-14 Evangelos Hytopoulos Methods for analysis of biological dataset profiles
US7483554B2 (en) 2003-11-17 2009-01-27 Aureon Laboratories, Inc. Pathological tissue mapping
US7505948B2 (en) 2003-11-18 2009-03-17 Aureon Laboratories, Inc. Support vector regression for censored data
US7461048B2 (en) 2003-07-21 2008-12-02 Aureon Laboratories, Inc. Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
US20050136509A1 (en) 2003-09-10 2005-06-23 Bioimagene, Inc. Method and system for quantitatively analyzing biological samples
US7760927B2 (en) 2003-09-10 2010-07-20 Bioimagene, Inc. Method and system for digital image based tissue independent simultaneous nucleus cytoplasm and membrane quantitation
WO2005091203A2 (en) 2004-03-12 2005-09-29 Aureon Laboratories, Inc. Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
WO2006020627A1 (en) 2004-08-11 2006-02-23 Aureon Laboratories, Inc. Systems and methods for automated diagnosis and grading of tissue images
US20060063190A1 (en) 2004-09-22 2006-03-23 Tripath Imaging, Inc Methods and compositions for evaluating breast cancer prognosis
EP1645881A1 (de) 2004-10-05 2006-04-12 DKFZ Deutsches Krebsforschungszentrum Screening-Verfahren zum Auffinden und Charakterisieren von Protein-Protein-Wechselwirkungen in vivo durch "fluorescence cross correlation spectroscopy"
US20060159325A1 (en) 2005-01-18 2006-07-20 Trestle Corporation System and method for review in studies including toxicity and risk assessment studies
US7537894B2 (en) 2005-03-02 2009-05-26 The University Of Chicago Methods and kits for monitoring Barrett's metaplasia
US20070019854A1 (en) 2005-05-10 2007-01-25 Bioimagene, Inc. Method and system for automated digital image analysis of prostrate neoplasms using morphologic patterns
US7599893B2 (en) 2005-10-13 2009-10-06 Aureon Laboratories, Inc. Methods and systems for feature selection in machine learning based on feature contribution and model fitness
GB0521521D0 (en) 2005-10-21 2005-11-30 Medical Res Council Diagnostic methods and kits
GB2433986A (en) 2006-01-09 2007-07-11 Cytokinetics Inc Granularity analysis in cellular phenotypes
US20090170091A1 (en) 2006-01-17 2009-07-02 Kenneth Giuliano Method For Predicting Biological Systems Responses
KR20080094803A (ko) 2006-01-27 2008-10-24 트리패스 이미징, 인코포레이티드 난소암의 발병 가능성이 높은 환자를 확인하는 방법 및 그의 조성물
US20090317836A1 (en) 2006-01-30 2009-12-24 The Scripps Research Institute Methods for Detection of Circulating Tumor Cells and Methods of Diagnosis of Cancer in Mammalian Subject
DK2032982T3 (da) 2006-05-05 2012-11-05 Univ Yale Anvendelse af subcellulær lokaliseringsprofiler som prognostiske eller prædiktive indikatorer
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
US7706591B2 (en) 2006-07-13 2010-04-27 Cellomics, Inc. Neuronal profiling
US7811778B2 (en) 2006-09-06 2010-10-12 Vanderbilt University Methods of screening for gastrointestinal cancer
US20100112602A1 (en) 2006-11-10 2010-05-06 Taylor Lansing D Protein-Protein Interaction Biosensors and Methods of Use Thereof
US9758833B2 (en) 2008-02-19 2017-09-12 The Johns Hopkins University Methods for predicting esophageal adenocarcinoma (EAC)
WO2010121266A1 (en) 2009-04-18 2010-10-21 The Regents Of The University Of Michigan Targeted detection of dysplasia in barrett's esophagus with a novel fluorescence-labeled polypeptide
US20140148348A1 (en) 2010-01-13 2014-05-29 Christine Kuslich Dectection of gastrointestinal disorders
JP2013526852A (ja) 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 疾患に対する循環バイオマーカー
WO2012024543A1 (en) * 2010-08-18 2012-02-23 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
AU2012229102B2 (en) 2011-03-17 2016-02-04 Cernostics, Inc. Systems and compositions for diagnosing Barrett's esophagus and methods of using the same
ES2650230T3 (es) 2011-09-23 2018-01-17 Academisch Medisch Centrum Materiales y métodos para pronóstico de evolución de esófago de Barrett
US10962544B2 (en) 2015-11-25 2021-03-30 Cernostics, Inc. Methods of predicting progression of Barrett's esophagus

Also Published As

Publication number Publication date
EP3380840B1 (de) 2020-08-19
AU2016359685A1 (en) 2018-06-14
CA3006356A1 (en) 2017-06-01
IL275126A (en) 2020-07-30
EP3786640A1 (de) 2021-03-03
ES2931924T3 (es) 2023-01-04
EP3380840A1 (de) 2018-10-03
EP3380840A4 (de) 2019-06-26
IL275126B (en) 2021-05-31
AU2023200590A1 (en) 2023-03-09
AU2016359685B2 (en) 2022-12-22
IL259561A (en) 2018-07-31
WO2017091658A1 (en) 2017-06-01
US10962544B2 (en) 2021-03-30
EP3786640B1 (de) 2022-08-24
EP4152001A1 (de) 2023-03-22
ES2831754T3 (es) 2021-06-09
US20220034894A1 (en) 2022-02-03
US20180348226A1 (en) 2018-12-06

Similar Documents

Publication Publication Date Title
AU365268S (en) Pendant
AU363638S (en) Pendant
IL257026A (en) Solid state forms of eluxadoline
HK1248069A1 (zh) 去乙酰氧基微管溶素h及其類似物
IL285882A (en) Medicinal uses for l–4–chlorokynurenine
ZA201706282B (en) Solid forms of menaquinols
PL3329145T3 (pl) Taśma lub segment taśmy
GB201604627D0 (en) Improved method of FT-IMS
IL275126B (en) Methods for predicting the progression of Barrett's esophagus
GB2536793B (en) Endoscope
HK1257488A1 (zh) 骨形成
GB201522618D0 (en) Methods of screening
GB201512139D0 (en) Methods of treatment
GB201721386D0 (en) Chrondogy of time-wave
GB201712596D0 (en) Improved photobioreactor
GB201706621D0 (en) Biomarkers of barrett's esophagus
PT3377106T (pt) Modulação da ciliogénese
ZA201603748B (en) Direct reduction of diamminedichloropalladium (ii) salt
PT3377478T (pt) Co-cristais de bilastina
GB201520382D0 (en) Sports aid
GB201518747D0 (en) Sports aid
AU365117S (en) Tongue Anteriorizor
GB201503465D0 (en) Sequencing methods
GB201700900D0 (en) Sequencer
GB201508547D0 (en) Sports aid

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed